PAY WITH VISA, MASTERCARD, INTERAC

How peptide ingredient labeling works for researchers

Authors

1012874pwpadmin
Scientist reviewing peptide label and COA in lab

A compliant, research-usable peptide label sold in Canada must show the INCI or chemical name, a lot/batch identifier, net peptide content or concentration, storage conditions, expiry date, manufacturer or dealer contact, and a lot-specific Certificate of Analysis (COA) containing HPLC purity data and LC-MS identity confirmation. That is the minimum. Anything less is a documentation gap that can compromise experimental reproducibility or regulatory standing.

The core referents here are Health Canada’s Cosmetic Regulations and the INCI naming system. For lot-specific COAs in practice, Peptilab sets the standard with third-party-verified HPLC and LC-MS data attached to every shipped lot.

At a glance, a compliant peptide label must include:

  • INCI name (or chemical name if no INCI exists)
  • Lot or batch number
  • Net peptide content or concentration (mg, % w/w, or mg/mL)
  • Storage conditions and expiry or manufacture date
  • Manufacturer or Canadian dealer contact information
  • Reference to a lot-specific COA with HPLC and LC-MS data

Table of Contents

What must appear on a peptide label?

Understanding peptide ingredients starts with knowing which label elements are non-negotiable versus expected best practice. The table below separates them.

Element Required or expected Notes
INCI or chemical name Required (cosmetics) Chemical name mandatory if no INCI exists
Net peptide content Required State in mg, % w/w, or mg/mL
Lot/batch number Required Enables COA traceability
Expiry or manufacture date Required Both preferred for research use
Storage conditions Required Temperature, light, humidity
Manufacturer/dealer contact Required Canadian dealer address for domestic products
Bilingual labelling Required where applicable English and French for consumer-facing products
Lot-specific COA reference Expected best practice HPLC purity, LC-MS identity minimum

Checklist for procurement validation:

  • Confirm the ingredient name matches the current INCI Dictionary or a recognized chemical authority
  • Verify net peptide content is stated separately from total product weight or excipient mass
  • Check that the lot number on the outer label matches the COA exactly
  • Confirm storage temperature and expiry are legible and will remain so through the product’s useful life
  • Request the full COA before accepting a shipment, not after

Health Canada’s labelling guidance specifies that the ingredient list, product identity, net quantity, dealer contact, and safety directions must all appear on the label, with ingredients listed using the INCI system.

How should peptides be named and identified?

The Cosmetic Regulations require every cosmetic ingredient to be listed by its INCI name. If no INCI name exists for a peptide, the regulation mandates using the chemical name from a recognised authority. The preferred order is: CAS-registered name, IUPAC name, Merck Index name, International Non-Proprietary Name (INN), or pharmacopoeia name.

Gloved hands holding peptide label and COA on lab bench

For peptide sequences specifically, the label or COA should express the sequence using standard one-letter or three-letter amino acid codes, written N-terminus to C-terminus. Three-letter codes (e.g., Fly-Pro-Hyp) are more readable in documentation; one-letter codes (e.g., GPO) are compact and common in databases. Any modifications, protecting groups, or non-standard residues must be noted explicitly.

CAS numbers are useful supplementary identifiers and appear in the INCI Dictionary alongside empirical formulas and trade names. They do not replace the INCI or chemical name on the outer label, but they are valuable for cross-referencing literature and supplier databases.

Naming checklist:

  • INCI name from the current ICI Dictionary (first choice)
  • Chemical name from CAS, IUPAC, or Merck Index if no INCI exists
  • Sequence notation: one-letter or three-letter codes, N→C direction, modifications flagged
  • CAS number as a supplementary identifier on the COA
  • Lot code unique to the shipped batch for traceability

Pro Tip: Insist that suppliers never substitute a proprietary internal code for the INCI or chemical name on the outer label. An internal code is untraceable in any public database and fails the regulatory requirement outright.

Quantities, units, and how to convert between them

The difference between net peptide content and total product mass matters more than most labels make clear. Net peptide content is the mass of the actual peptide molecule in the vial, excluding water, counter-ions, and excipients. Total product weight includes all of those. For a lyophilised peptide with 15% water content and a TFA counter-ion, the net peptide content can be meaningfully lower than the stated gross weight.

Common units by context:

  1. mg — standard for lyophilised research peptides; net peptide content stated in mg per vial
  2. % w/w — used in cosmetic formulations; mass of peptide per total formulation mass
  3. mg/mL — used for liquid formulations and stock solutions
  4. µg/mg — used when peptide concentration within a carrier matrix is very low
  5. µM or nM — used in bioassay contexts; requires molecular weight for conversion

Worked conversion examples:

To convert mg to molarity for a stock solution:

Molarity (µM) = [mass (µg) ÷ molecular weight (g/mol)] × 1000 ÷ volume (mL)

For a 1 mg vial of a peptide with MW 1,500 g/mol dissolved in 1 mL:
(1,000 µg ÷ 1,500) × 1,000 ÷ 1 = 667 µM

To convert % w/w to mg/mL (assuming aqueous formulation density ≈ 1.0 g/mL):

mg/mL = % w/w × 10

A 0.5% w/w peptide formulation contains 5 mg/mL.

Conversion Formula Assumption
mg → µM (mg × 1,000 ÷ MW) ÷ volume (mL) MW in g/mol
% w/w → mg/mL % × 10 Density = 1.0 g/mL
mg/mL → % w/w mg/mL ÷ 10 Density = 1.0 g/mL
µM → mg/mL — MW in g/mol

Infographic showing peptide labeling key steps in vertical flow

What should a Certificate of Analysis contain?

Lot-specific HPLC and LC-MS traces are the most effective single trust signals linking analytical data to a shipped peptide lot. A summary purity statement without attached chromatograms is not sufficient for research-grade procurement.

Core COA elements:

Test What it confirms Threshold (research grade)
HPLC purity (%) Peptide purity relative to all UV-absorbing species >95% minimum; >99% for biomedical assays
LC-MS identity Molecular ion match to theoretical MW [M+H]⁺, [M+2H]²⁺ adducts; no major truncations
Water content (Karl Fischer) Hydration state; affects net peptide content Typically <10% for lyophilised peptides
Residual solvents Acetonitrile, TFA, DMF traces ICH Q3C limits apply
Endotoxin (LAL) Bacterial contamination <1 EU/mg for cell-based assays
Elemental analysis Confirms empirical formula Optional; used for absolute quantification

Reading HPLC purity: the percentage reflects the area of the main peak relative to all integrated peaks in the chromatogram. A >99% HPLC purity means less than 1% of UV-absorbing material is anything other than the target peptide. For biomedical assays where off-target activity is a concern, anything below 95% warrants rejection or re-purification.

Interpreting LC-MS: look for the expected molecular ion (M+H)⁺ or doubly charged (M+2H)²⁺ adduct. The observed mass should match the theoretical mass within ±0.5 Da for small peptides. Peaks at M-17 or M-18 suggest deamidation or dehydration. Peaks significantly lower in mass than expected indicate truncated sequences.

Pro Tip: Request the raw chromatogram file or a high-resolution PDF of the HPLC trace, not just the purity percentage. A single number without the peak shape tells you nothing about co-eluting impurities.

Excipients, counter-ions, and contaminants: what must be declared

Counter-ions are the most commonly underdeclared component on peptide labels. Most synthetic peptides are supplied as TFA (trifluoroacetate) salts because TFA is used in HPLC purification. A peptide labelled simply as “Peptide X, 10 mg” without declaring the TFA salt form is incomplete. The correct declaration is “Peptide X (trifluoroacetate)” or “Peptide X·TFA.” This matters because TFA changes the molecular weight used in molarity calculations and can be cytotoxic at higher concentrations in cell-based assays.

Acetate-exchanged peptides are a cleaner alternative for cell work and should be declared as “Peptide X (acetate).” The counter-ion swap changes the net peptide content per mg of product.

Contaminant reporting that matters to researchers:

  • Residual solvents: acetonitrile and DMF are common; ICH Q3C limits apply
  • Water content: Karl Fischer titration; high water content reduces effective peptide dose
  • Heavy metals: ICP-MS where elemental purity is critical
  • Endotoxin: LAL test; required for any in vivo or cell-based assay

For cosmetic formulations, excipients such as preservatives (phenoxyethanol, benzyl alcohol) and emulsifiers must be listed by INCI name in descending order of concentration. Fragrance mixtures may be declared as “parfum” under the Cosmetic Regulations, but specified allergens above threshold concentrations must be listed individually.

Pro Tip: For cell-based assays, always confirm the counter-ion before calculating your working concentration. A 10 mg vial of a TFA salt may contain only 7–8 mg of net peptide depending on the peptide’s charge state and MW.

Canadian regulatory distinctions you need to know

The regulatory pathway for a peptide in Canada depends entirely on its intended use, and mislabelling a therapeutic peptide as a cosmetic is a serious compliance failure.

Cosmetics fall under the Cosmetic Regulations. The INCI labelling requirement applies to all cosmetics sold in Canada, and the ingredient list must appear on the outer label in descending order of concentration by weight. Ingredients present at 1% or less may be listed in any order after those above 1%.

Small container exception: when the immediate container or outer package is too small for standard labelling, the Cosmetic Regulations permit condensed labelling that lists ingredients with exact concentrations or concentration ranges rather than simple descending order.

Colourant multi-shade exception: for makeup and nail polish sold in a range of shades, all colouring agents used across the range may be listed collectively, preceded by “+/−”, “±”, or the phrase “may contain/peut contenir.”

Under section 21.2(2) of the Cosmetic Regulations, colouring agents in a multi-shade range may be listed collectively if preceded by “+/−” or “±” or the phrase “may contain/peut contenir.” This exception applies only to colourants and does not extend to active peptide ingredients, which must each be individually declared.

Research-use-only peptides are not subject to cosmetic labelling rules, but they must be clearly labelled as “for research use only, not for human use” and must not carry therapeutic claims. Therapeutic peptides follow drug regulations under the Food and Drugs Act and require a Drug Identification Number (DIN) or an Investigational New Drug (IND) submission. Labelling a therapeutic peptide as a cosmetic to avoid drug regulation is a regulatory offence.

How to review a peptide label and COA before use

Supplier qualification checklist:

  • Confirmed amino acid sequence matches the label and COA
  • INCI or chemical name on the label matches the COA header
  • Lot number on the outer label is identical to the lot number on the COA
  • COA date is specific to the shipped lot, not a generic batch document
  • HPLC chromatogram is attached (not just a purity percentage)
  • LC-MS spectrum is attached with observed and theoretical mass stated
  • Declared purity and the analytical method used are both stated
  • Water content (Karl Fischer) is reported
  • Residual solvents are reported with values against ICH Q3C limits
  • Counter-ion is declared
  • Storage temperature and expiry date are present and legible
  • Manufacturer or Canadian dealer contact information is present

Red flags that warrant rejection or clarification:

  • No LC-MS data attached
  • A single COA covering multiple lot numbers
  • Proprietary internal codes used instead of INCI or chemical names
  • Missing storage instructions
  • Counter-ion undeclared or listed only as “salt form”
  • Purity stated without the method used to measure it

Pro Tip: Require a signed statement from the supplier confirming that the attached COA corresponds to the specific lot shipped. A COA without that confirmation is a template, not a lot-specific document.

Annotated sample label and COA cross-reference

The table below maps each outer label element to the COA field that should corroborate it. Use this as a procurement SOP template.

Outer label text Corresponding COA field Acceptable evidence
Peptide name (INCI/chemical) Compound name / structure INCI name or IUPAC name match
Net peptide content: 10 mg Assay result (mg) Assay ≥ stated net content
Lot number: XXXX Lot/batch number Exact alphanumeric match
Purity: >99% HPLC purity (%) Chromatogram attached, area ≥ 99
Identity confirmed LC-MS result Observed MW within ±0.5 Da of theoretical
Water content Karl Fischer result Value stated in %
Storage: protect from light Storage conditions Matches label instruction
Expiry: MM/YYYY Expiry date Date on COA ≥ date on label
Manufacturer contact Manufacturer/supplier field Canadian dealer address present

Incoming-goods checklist (paste into purchase orders):

  • Outer label lot number matches COA lot number: ☐
  • HPLC chromatogram attached: ☐
  • LC-MS spectrum attached: ☐
  • Purity ≥ stated threshold: ☐
  • Water content reported: ☐
  • Counter-ion declared: ☐
  • Storage and expiry legible: ☐
  • Manufacturer contact present: ☐

Numbered verification steps for lab intake:

  1. Cross-check the lot number on the vial against the COA header before opening.
  2. Confirm the HPLC purity value and attach the chromatogram to the batch record.
  3. Record the LC-MS observed mass and compare to the theoretical value.
  4. Note the water content and adjust net peptide content calculations accordingly.
  5. Log the counter-ion form before preparing any stock solution.

Best practices for sourcing peptides in Canada

Canadian sourcing matters for more than just shipping speed, as demonstrated by consumer peptide packaging that illustrates key labelling differences in nutraceutical products. Domestic suppliers operate under Health Canada’s regulatory framework, which means their labelling and documentation practices must align with the Cosmetic Regulations and accepted analytical standards. That alignment reduces the compliance burden on your QA team.

For sourcing research-grade peptides in Canada, the non-negotiables are lot-specific COAs with HPLC and LC-MS attachments, third-party testing for critical lots, and a clear chain of custody from synthesis to delivery. Peptilab provides third-party tested lot-specific COAs with HPLC results and maintains Canadian manufacturing and fulfilment, which eliminates import delays and the documentation uncertainty that comes with cross-border shipments.

Supplier due diligence checklist:

  • Lot-specific COAs with HPLC and LC-MS attachments (not batch summaries)
  • Third-party testing available on request for critical research lots
  • Canadian manufacturing or fulfilment address stated on documentation
  • Clear chain of custody from synthesis to delivery
  • Responsive to technical questions about analytical methods

Recordkeeping for QA/QC:

  • Archive every COA with the corresponding lot number and receipt date
  • Log any lot switches in your change control records and note the analytical comparison
  • Retain third-party test reports separately from supplier-issued COAs

Pro Tip: For any critical assay, run a small pilot comparison between a new lot and the prior lot before committing the full quantity to experiments. A purity difference of even 2–3% can shift dose-response curves in sensitive cell-based systems.

Key takeaways

A compliant peptide label requires the INCI or chemical name, a lot-specific COA with HPLC and LC-MS data, declared counter-ions, and verified storage and expiry information — treat the COA as an analytical instrument, not a formality.

Point Details
INCI or chemical name required Health Canada mandates INCI for cosmetics; chemical name from CAS or IUPAC if no INCI exists.
Lot-specific COA is non-negotiable HPLC chromatogram and LC-MS spectrum must be attached, not summarized.
Declare counter-ions explicitly TFA or acetate salt form changes MW calculations and can affect cell-based assay results.
Net peptide content vs gross weight Water content and counter-ions reduce effective peptide dose; always calculate from net content.
Peptilab for Canadian sourcing Peptilab supplies lot-specific, third-party-verified COAs with Canadian fulfilment and no import delays.

Why complete labelling matters more than most labs realise

The conventional view is that a COA is a compliance document. It is not. It is the only instrument you have for deciding whether a peptide lot is fit for a specific experiment. A purity percentage without a chromatogram is like a blood pressure reading without knowing the cuff size: the number exists, but you cannot trust what it represents.

The part most procurement teams underestimate is the counter-ion problem. A lab receives a 10 mg vial labelled simply as “Peptide X.” No counter-ion declared. The researcher dissolves it and prepares a 1 mM stock. If the peptide is a TFA salt with a high charge state, the actual peptide content could be closer to 7 mg, and the stock is already 30% below the intended concentration before the first pipette touches it. That error propagates through every downstream experiment in the series.

The fix is not complicated. Demand full documentation before the vial is opened. Treat the COA as a prerequisite, not an afterthought. Labs that build this into their incoming-goods SOP catch lot-quality issues before they become data-quality issues. The ones that do not tend to find out three months later when a result cannot be replicated.

Peptilab: COA-backed peptides with Canadian fulfilment

Canadian researchers who need high-purity research peptides with full analytical documentation do not have to choose between speed and compliance. Peptilab ships domestically, which means no customs delays, no import documentation gaps, and no ambiguity about which regulatory framework applies to your shipment.

Peptilab

Every Peptilab lot ships with a lot-specific COA that includes HPLC purity data and LC-MS identity confirmation, verified through third-party testing. For teams working on rare disease research or cosmetic peptide development, that documentation standard is built in, not available on request. Browse the full peptide catalogue or contact Peptilab directly to request lot-specific documentation for your next procurement.

Useful sources and references

The sources below are the primary references for Canadian peptide labelling requirements. Consult them directly when confirming regulatory obligations for your specific product category.

  • Cosmetic Regulations (C.R.C., c. 869) — The primary legal instrument governing ingredient labelling for cosmetics in Canada. Sections 21.1–21.5 cover INCI requirements, the chemical name fallback, descending order of predominance, the colourant multi-shade exception, and small-container condensed labelling rules.

  • Health Canada: Cosmetic advertising, labelling and ingredients — Health Canada’s consumer-facing summary of mandatory label elements including product identity, net quantity, dealer contact, and the INCI ingredient list requirement.

  • Health Canada: Labelling of Cosmetics (Consumer Product Safety) — Explains why mandatory INCI names support unambiguous ingredient identification and help clinicians identify sensitivity-causing ingredients.

  • Industry Guide for the Labelling of Cosmetics — Health Canada’s practical guidance document for manufacturers and importers. Covers descending order of predominance, the below-1% exception, botanical naming, fragrance notation (“parfum”/“aroma”), and legibility requirements through the product’s useful life.

  • Guide to Cosmetic Ingredient Labelling (PDF) — Detailed worked examples for ingredient listing, INCI Dictionary cross-referencing, and instructions for ingredients without INCI names.

  • Peptilab: Why use third-party peptide testing for research — Explains what to request in a COA and why lot-specific HPLC and LC-MS traces are the principal trust signals for research-grade peptide procurement.

Regulatory requirements for cosmetic labelling in Canada are set by the Cosmetic Regulations under the Food and Drugs Act. For therapeutic peptides, the Food and Drug Regulations and Natural Health Products Regulations apply instead. Always confirm which pathway governs your product before finalising label content.

This article is general information for research and educational purposes. Confirm current regulatory requirements with Health Canada or a qualified regulatory professional for your specific product and intended use.